Pharmacists in community-based practice.
Universal program number: 0401-0000-13-004-H01-P
Activity type: Knowledge-based
To review the pharmacological treatment options for chronic hepatitis C and provide practical considerations on drug adherence, adverse effects and drug interactions.
As members of the healthcare team, pharmacists can raise hepatitis C awareness in the community, assist physicians in improving patient care and most importantly, provide the knowledge and support patients require emotionally and medically in treating hepatitis C. Pharmacists are in an ideal position to improve patient adherence and help manage the adverse effects associated with HCV therapy.
Upon completion of this program, the pharmacist should be able to:
- Discuss the epidemiology, risk factors and natural history of hepatitis C infection.
- Review the current literature, guidelines and pharmacologic strategies used in treatment-naive and treatment-experienced patients infected with hepatitis C.
- Select appropriate drug treatment for a patient infected with chronic hepatitis C infection based on viral genotype.
- Review counseling strategies to minimize adverse effects and maximize adherence rates in patients undergoing hepatitis C treatment.
- Identify and review potential drug-drug interactions prior to initiating hepatitis C therapy with the approved direct antiviral agents.
To obtain credit:
A minimum test score of 70% is needed to obtain credit. Submit your answers to the learning assessment questions online at DrugStoreNewsCE.com. Your statement of credit will be available through CPE Monitor located at NABP.net. To ensure transmission of credit hours to CPE Monitor, you must enter your correct e-PID number in your CE profile.
All customer service questions should be directed to (800) 933-9666.
If you are a paid enrollee, there is no cost to participate in this lesson. The fee for participants who are not enrolled is $13.95.
Drug Store News is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This CPE Activity is approved for pharmacists and is worth 2.0 contact hours (0.2 CEUs). The activity is available for CE credit through April 4, 2016.